Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting epidermal growth factor receptor (EGFR) pathways. Shows potential in anticancer drug development due to its ability to enhance selectivity and solubility in active compounds. Also employed in structure-activity relationship (SAR) studies to optimize quinazoline-based therapeutics for improved metabolic stability and bioavailability.